NEW YORK (GenomeWeb News) - Roche NimbleGen said today it has expanded a patent license agreement with Affymetrix to include diagnostic rights to array-based DNA analysis and array-based re-sequencing.
 
NimbleGen and Affymetrix originally agreed to the patent license, which gave NimbleGen the rights to patents related to the manufacture, use, and sale of nucleic acid microarrays, in October 2006
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.